Millions of Americans use GLP-1 injections like Ozempic to lose weight. A study is questioning whether they can cause vision loss.

Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA Psychiatry, researchers report that semaglutide, better known as Ozempic or Wegovy, helped people with alcohol addiction reduce their craving and drink less.

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

Those too slim to be eligible for injections can no longer get prescription without seeing a doctor under new guidance

The new findings add to growing evidence that the medicines could help people with alcohol addiction. View on euronews